Maity cares for patients with hematologic malignancies using radiation therapy, a type of treatment that delivers precise beams of energy to shrink or kill tumors within the body. His laboratory focuses on ways to improve the efficacy of radiation therapy through research in new therapeutics that may enhance the sensitivity of tumor cells to radiation.
"Dr. Maity is a national leader in his field," said Michael L. Good, MD, CEO of 麻豆学生精品版. "His expertise, experience, and leadership will help bring an already exceptional department to even greater heights in caring for our patients, advancing research, and training the next generation of clinicians and scientists."
As chair, Maity will oversee all radiation oncology clinical care, research, and training programs at U of U Health. The department is located at Huntsman Cancer Institute, the only National Cancer Institute-designated Comprehensive Cancer Center in the Mountain West. The department provides radiation oncology care to adults and children in one of the largest services areas in the country, an area that includes Utah, Idaho, Montana, Nevada, and Wyoming, and comprises 17 percent of the landmass of the continental United States. As home to the region鈥檚 first and only center for proton therapy among all other state-of-the-art radiation therapy modalities, the department is broadly recognized for expertise in medical physics with sophisticated technologies for precision-guided delivery of radiation therapy. Clinical trials evaluating new methods of radiation therapy for cancer patients is a priority of the department. A major focus of its clinical research efforts is evaluation of methods that reduce the number of radiation therapy doses required to treat a tumor, an effort to meet unique needs of HCI鈥檚 rural service area where many patients must travel significant distances for such treatment.
"We are thrilled to welcome Dr. Maity to Huntsman Cancer Institute," said Sachin Apte, MD, chief clinical officer of HCI. "Approximately half of all cancer patients receive radiation therapy as part of their treatment. Radiation therapy is a critical area of focus for Huntsman Cancer Institute in terms of advancing compassionate, science-based medicine and training the next generation of radiation therapy care providers."
Maity completed his medical degree at Boston University, followed by a residency in internal medicine at Mount Sinai Hospital in New York and then a residency in radiation oncology at the Hospital of the University of Pennsylvania. He subsequently completed a PhD at the University of Pennsylvania and then pursued post-doctoral research training at Johns Hopkins University, and later leadership training at Harvard University.
"I am excited by the opportunity at 麻豆学生精品版 and Huntsman Cancer Institute because of their commitment to exceptional patient-centered cancer care, and to cutting-edge research aimed at improving outcomes," said Maity. "I am looking forward to working with the exceptionally talented teams there and helping them to achieve even more in our field." 
Maity begins his service on June 1, 2022. He succeeds Dennis Shrieve, MD, PhD, who has served as chair of the department since 2000. Shrieve will remain on staff where he will continue to care for cancer patients at HCI. "We are extremely grateful to Dr. Shrieve for his visionary leadership of the department of radiation oncology for over two decades, and for his continued service to cancer patients," said Good. "Dr. Shrieve was instrumental in bringing new modalities, like stereotactic radiosurgery and proton therapy to Utah, and his leadership of the department has brought together a robust group of radiation oncologists, medical physicists, dosimetrists, technicians, administrative professionals and more who are united in advancing radiation therapy care for the benefit of cancer patients."